WST

West Pharmaceutical Services Inc Earnings

$331.4

Earnings Summary

Revenue	$746.9Mn
Net Profits	$136Mn
Net Profit Margins	18.21%

Highlights

Revenue:

West Pharmaceutical Services Inc’s revenue fell -0.07% since last year same period to $746.9Mn in the Q3 2024. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 6.4% jump in its revenue since last 3-months.

Net Profits:

West Pharmaceutical Services Inc’s net profit fell -15.69% since last year same period to $136Mn in the Q3 2024. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 22.19% jump in its net profits since last 3-months.

Net Profit Margins:

West Pharmaceutical Services Inc’s net profit margin fell -15.63% since last year same period to 18.21% in the Q3 2024. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 14.85% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the West Pharmaceutical Services Inc post its latest quarter earnings

EPS Estimate Current Quarter	1.71
EPS Estimate Current Year	1.71

Highlights

EPS Estimate Current Quarter:

West Pharmaceutical Services Inc’s earning per share (EPS) estimates for the current quarter stand at 1.71 - a 14% jump from last quarter’s estimates.

EPS Estimate Current Year:

West Pharmaceutical Services Inc’s earning per share (EPS) estimates for the current year stand at 1.71.

Key Ratios

Key ratios of the West Pharmaceutical Services Inc post its Q3 2024 earnings

Earning Per Share (EPS)	1.85
Dividend Per Share (DPS)	0.2

Highlights

Earning Per Share (EPS):

West Pharmaceutical Services Inc’s earning per share (EPS) fell -14.35% since last year same period to 1.85 in the Q3 2024. This indicates that the West Pharmaceutical Services Inc has generated -14.35% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Dividend Per Share (DPS):

West Pharmaceutical Services Inc declared 0.2 dividend per share during the earnings announcement for Q3 2024.

Earnings Calendar

Earnings Date	Estimated EPS	Reported EPS	Surprise %
2024-07-25	1.74	1.52	-12.64%
2024-10-24	1.5	1.85	23.33%
2024-04-25	1.26	1.56	23.81%

Discover More Earning Stocks in Health Technology Sector

Viking Therapeutics, Inc. Earnings

Iovance Biotherapeutics, Inc. Earnings

Teva Pharmaceutical Industries Ltd Earnings

Springworks Therapeutics Inc Earnings

Become a Global Investor

Start Investing in brands you love

₹0 US Stocks a/c Opening Fee
₹0 Maintenance Charges
₹0 US Stocks Withdrawals*

Invest Now

*Investment in securities market are subject to market risk, read all the related documents carefully before investing. Logos above are the property of their respective trademark owners and by displaying it INDmoney has no right, title or interest over it.

The connector service for US Stocks account is provided by Finzoomers Services Private Limited.

Please be informed that US Stocks are not Indian Exchange traded funds and Finzoomers Services Private Limited merely acts in the capacity of a facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to exchange investor redressal forum or arbitration mechanism in India. The securities quoted are for examples and not to be considered as an advice or recommendation.